Eyeing ‘fertile’ climate for biotechs, J&J building presence in Singapore

Through a new agreement with a government-backed entity, J&J aims to foster growth of Singapore-based start-ups, driven by the conviction that the country offers a ripening environment for young biotechs to deliver on the promise of strong science and manufacturing.

This week, Johnson & Johnson Innovation and Singapore’s Economic Development Bureau launched an initiative through which Johnson & Johnson (NYSE:JNJ) will provide resources to support translational projects, work with sources of capital, and draw talent to the island nation...